Sarbjit Singh Jhamb
Overview
Explore the profile of Sarbjit Singh Jhamb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar V, Jhamb S, Sobhia M
J Biomol Struct Dyn
. 2017 Oct;
36(12):3274-3290.
PMID: 28974157
The arising cases of isoniazid-resistance have motivated research interests toward new class of molecules known as direct InhA inhibitors. Here, a combine approach of shape-based pharmacophore and descriptor-based 2D QSAR...
2.
Singh C, Koduri L, Bhatt T, Jhamb S, Mishra V, Gill M, et al.
AAPS PharmSciTech
. 2016 Feb;
18(1):138-146.
PMID: 26902373
The objective of this study comprises of developing novel co-spray dried rifampicin phospholipid lipospheres (SDRPL) to investigate its influence on rifampicin solubility and oral bioavailability. Solid-state techniques were employed to...
3.
Jhamb S, Goyal A, Singh P
Braz J Infect Dis
. 2014 Apr;
18(3):336-40.
PMID: 24709416
BACTEC 460 has now been phased out, so the search for an alternative is imperative. We have determined the activity of standard anti-tuberculosis drugs against intramacrophage Mycobacterium tuberculosis, in vitro,...
4.
Singh R, Jhamb S, Singh P
Indian J Microbiol
. 2012 Oct;
49(3):276-82.
PMID: 23100782
The immunomodulatory effects of opioids are known in various infections. However, little is known about the effects of opioids in tuberculosis (TB). In the present study, we report the effects...
5.
Patel K, Jhamb S, Singh P
J Lab Physicians
. 2012 Jan;
3(2):75-9.
PMID: 22219558
Latent tuberculosis is a subclinical condition caused by Mycobacterium tuberculosis, which affects about one-third of the population across the world. To abridge the chemotherapy of tuberculosis, it is necessary to...
6.
Jhamb S, Singh P
Scand J Infect Dis
. 2009 Nov;
41(11-12):886-9.
PMID: 19922075
Screening of new agents for anti-tubercular activity is a challenging task due to the virulent and slow growing nature of mycobacteria. In this study, we explored the use of Mycobacterium...
7.
Kharatmal S, Jhamb S, Singh P
J Microbiol Methods
. 2009 May;
78(2):161-4.
PMID: 19454297
Mycobacterium tuberculosis exhibits latent state due to its ability to survive for extended periods under oxygen depletion conditions. The conventional plating method employed for in vitro screening of antitubercular agents...
8.
Jhamb S, Singh R, Singh P
Indian J Tuberc
. 2008 Jun;
55(2):70-6.
PMID: 18516822
Background: Presently, in vitro and in vivo screening of anti-tubercular drugs is a time-consuming exercise. Therefore, it is important to develop faster methods. Material And Methods: Towards this end, conventional...
9.
Singh R, Jhamb S, Singh P
Life Sci
. 2008 Jan;
82(5-6):308-14.
PMID: 18191418
The effects of opiates in various infections are well known; however, very little is known about tuberculosis infection. Therefore, in the present study, we report for the first time, the...
10.
Monga V, Nayyar A, Vaitilingam B, Palde P, Jhamb S, Kaur S, et al.
Bioorg Med Chem
. 2004 Nov;
12(24):6465-72.
PMID: 15556764
Additional structural modifications of the new chemical entity, 2,8-dicyclopentyl-4-methylquinoline (DCMQ; MIC=6.25 microg/mL, M. tuberculosis H37Rv) resulted in the synthesis of four new series of the ring-substituted quinolinecarbohydrazides (series 1-4) constituting...